BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 28003013)

  • 1. Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke.
    Shrestha S; Coy S; Bekelis K
    Curr Pharm Des; 2017; 23(9):1377-1391. PubMed ID: 28003013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.
    Kapil N; Datta YH; Alakbarova N; Bershad E; Selim M; Liebeskind DS; Bachour O; Rao GHR; Divani AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):301-318. PubMed ID: 27461564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.
    Bhatia K; Ladd LM; Carr KH; Di Napoli M; Saver JL; McCullough LD; Hosseini Farahabadi M; Alsbrook DL; Hinduja A; Ortiz Garcia JG; Sabbagh SY; Jafarli A; Divani AA
    Curr Neurol Neurosci Rep; 2023 May; 23(5):235-262. PubMed ID: 37037980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.
    Ganetsky VS; Hadley DE; Thomas TF
    Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
    Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P
    Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.
    Lanitis T; Cotté FE; Gaudin AF; Kachaner I; Kongnakorn T; Durand-Zaleski I
    J Med Econ; 2014 Aug; 17(8):587-98. PubMed ID: 24831811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel oral anticoagulant management issues for the stroke clinician.
    Wassef A; Butcher K
    Int J Stroke; 2016 Oct; 11(7):759-67. PubMed ID: 27465882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
    Rubboli A; Agewall S; Huber K; Lip GY
    Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.
    Hernandez I; Zhang Y; Saba S
    Am J Cardiol; 2017 Nov; 120(10):1813-1819. PubMed ID: 28864318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.
    Caprio FZ; Bernstein RA; Alberts MJ; Curran Y; Bergman D; Korutz AW; Syed F; Ansari SA; Prabhakaran S
    Cerebrovasc Dis; 2014; 38(4):247-53. PubMed ID: 25401389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.